Package 0024-5920-02

Brand: kevzara

Generic: sarilumab
NDC Package

Package Facts

Identity

Package NDC 0024-5920-02
Digits Only 0024592002
Product NDC 0024-5920
Description

2 SYRINGE in 1 PACKAGE (0024-5920-02) / 1.14 mL in 1 SYRINGE

Marketing

Marketing Status
Marketed Since 2018-04-13
Brand kevzara
Generic sarilumab
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "b1eeca31-be2b-4c68-a7c0-220256a2b906", "openfda": {"nui": ["N0000190478", "N0000190480"], "unii": ["NU90V55F8I"], "spl_set_id": ["827bc01c-d379-4266-a18c-c7f904b76af3"], "pharm_class_epc": ["Interleukin-6 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Interleukin 6 Receptor Antagonists [MoA]"], "manufacturer_name": ["Sanofi-Aventis U.S. LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE in 1 PACKAGE (0024-5920-01)  / 1.14 mL in 1 SYRINGE (0024-5920-00)", "package_ndc": "0024-5920-01", "marketing_start_date": "20180413"}, {"sample": false, "description": "2 SYRINGE in 1 PACKAGE (0024-5920-02)  / 1.14 mL in 1 SYRINGE", "package_ndc": "0024-5920-02", "marketing_start_date": "20180413"}], "brand_name": "KEVZARA", "product_id": "0024-5920_b1eeca31-be2b-4c68-a7c0-220256a2b906", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Interleukin 6 Receptor Antagonists [MoA]", "Interleukin-6 Receptor Antagonist [EPC]"], "product_ndc": "0024-5920", "generic_name": "sarilumab", "labeler_name": "Sanofi-Aventis U.S. LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "KEVZARA", "active_ingredients": [{"name": "SARILUMAB", "strength": "150 mg/1.14mL"}], "application_number": "BLA761037", "marketing_category": "BLA", "marketing_start_date": "20170522", "listing_expiration_date": "20271231"}